Carfilzomib-based combination regimens are highly effective frontline therapies for multiple myeloma and Waldenström’s macroglobulinemia
Year: 2018
Type: article
Study design: Observational Study
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2891730833
